chrysophanic acid has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, TC; Darzynkiewicz, Z; Kapuscinski, J; Kelly, TR; Koyama, M; Takahashi, K; Watanabe, KA | 1 |
| Carter, SP; Darzynkiewicz, Z; Kapuscinski, J; Watanabe, KA | 1 |
2 other study(ies) available for chrysophanic acid and Leukemia L 1210
| Article | Year |
|---|---|
Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2. Derivatives of chrysophanol and emodin.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; DNA, Neoplasm; Emodin; Humans; Intercalating Agents; Leukemia L1210; Leukemia, Promyelocytic, Acute; Mice; Spectrum Analysis; Tumor Cells, Cultured | 1989 |
Effect of derivatives of chrysophanol, a new type of potential antitumor agents of anthraquinone family, on growth and cell cycle of L1210 leukemic cells.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Cell Count; Cell Cycle; Cell Survival; DNA; Emodin; Flow Cytometry; Leukemia L1210; Mice; Tumor Cells, Cultured | 1989 |